Trials / Completed
CompletedNCT05282914
A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects
A Randomized, Open-label, Multiple-dose, Crossover Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics Between "UI058" and "UIC202004" in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Study to compare pharmacokinetics, pharmacodynamics and safety of UI058 and UIC202004 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | administration of UI058 | UI058 1Tab/day for 7days |
| DRUG | administration of UIC202004 | UIC202004 1Tab/day for 7days |
Timeline
- Start date
- 2021-02-03
- Primary completion
- 2021-04-14
- Completion
- 2021-09-01
- First posted
- 2022-03-16
- Last updated
- 2024-07-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05282914. Inclusion in this directory is not an endorsement.